The FDA has approved Lumakras with Vectibix for adults with KRAS G12C-mutated metastatic colorectal cancer who received chemotherapy. The Food and Drug Administration (FDA) has approved Lumakras ...
The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with unresectable or metastatic hormone receptor (HR)-positive, human epidermal ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved sotorasib with panitumumab for KRAS G12C-mutated colorectal cancer. The agency also ...
The authorization does not mean the products are safe or “FDA approved,” however. Perspective from Johannes Thrul, PhD The FDA announced it has authorized the marketing of 20 Zyn nicotine ...
The FDA also approved Netherlands-based Qiagen's (QIA.DE), opens new tab companion diagnostic device to identify patients eligible for the combination treatment. Lumakras is an oral drug designed ...
The approval is based on findings from the phase 3, multicenter, open-label, randomized TROPION-Breast01 trial. Today, the FDA approved datopotamab deruxtecan-dlnk (Datroway, Daiichi Sankyo ...
AstraZeneca and Daiichi's first co-developed ADC, Enhertu, was first approved by the FDA in 2019 for a type of breast cancer and later expanded for use in multiple conditions. In December ...
(RTTNews) - Eli Lilly and Co. (LLY) announced that the U.S. Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn's disease in ...
Advertisement It's the first time the FDA has approved marketing of nicotine pouches, which it describes as "small synthetic fiber pouches containing nicotine designed to be placed between a ...
The U.S. Food and Drug Administration (FDA) has approved 20 ZYN nicotine "pouch" products for sale after what it called "a thorough review." These nicotine pouches are small fiber pouches ...
Like New York Senator Chuck Schumer, who thinks the pouches need more federal oversight from the FTC and FDA, so kids don't get hooked. *** simple search of social media for Zen will generate an ...
Niktimvo is the first and only FDA-approved prescription treatment for chronic GVHD that targets CSF-1R to reduce the drivers of inflammation and fibrosis. The approved dose of Niktimvo for adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback